We previously showed that NKG7 marks resilient T cells that are critical to ICI response and, conversely, that Bim (BCL-2-interacting mediator of cell death) is upregulated in T cells by PD-L1/PD-1 engagement and drives poor anti-tumor immunity23,27,28. Here, BCL2L11 is linked to neoplasm.